SNCA and Parkinson disease: P2X7R involvement in α-synuclein-mediated microglial activation leads to ATP and ROS release, damaging dopaminergic neurons and contributing to PD pathology (Jiang et al., 2015; Wilkinson et al., 2017; Dos-Santos-Pereira et al., 2018).